Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: ZBIO) | Delayed: 28.23 -0.15 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.38 | 52 Week High | $50.95 | |||
| Open | $29.27 | 52 Week Low | $18.06 | |||
| Day High | $29.91 | P/E | N/A | |||
| Day Low | $28.01 | EPS | $0.00 | |||
| Volume | 62,746 | |||||
